HONG KONG--(BUSINESS WIRE)--Nov. 29, 2005--American Oriental Bioengineering Inc. (AMEX:AOB), a leading Chinese manufacturer and distributor of pharmaceutical and nutraceutical products, announced today that it has signed definitive agreements with accredited investors in respect to the previously announced offering of 12,500,000 units, each unit consisting of one share of its common stock and three-tenths of a warrant to purchase one share of its common stock, at a price of $4.80 per unit, for anticipated aggregate gross proceeds of $60 million. The warrants have an exercise price of $6.50 per share of common stock. The proceeds, net of offering fees and expenses, will be used to finance acquisitions and for general corporate purposes. The closing will take place after approval from the American Stock Exchange and the Archipelago Exchange (ArcaEx) of additional listing applications with respect to the securities to be issued in such offering.
